News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Mario Balsa: Real-world Comparison in Advanced HCC – Atezolizumab + Bevacizumab vs Tremelimumab + Durvalumab
Mario Balsa/X
Jun 25, 2025, 09:27

Mario Balsa: Real-world Comparison in Advanced HCC – Atezolizumab + Bevacizumab vs Tremelimumab + Durvalumab

Mario Balsa, Medical Oncology resident at ICO, shared a post on X:

“Real-world comparison in advanced HCC: Atezolizumab +Bevacizumab vs Tremelimumab +Durvalumab
>2,300 patients from TriNetX
No significant OS difference
Sometimes, the real drama lies in the tie
Congrats Andrea Casadei Gardini and the team!”

Title: Comparative Effectiveness of Atezolizumab Plus Bevacizumab Versus Tremelimumab Plus Durvalumab in Patients with Hepatocellular Carcinoma (HCC) in a Real-World Setting

Authors: Federica Lo Prinzi, Federico Rossari, Marianna Silletta, Silvia Camera, Silvia Foti, Mara Persano, Francesco Vitiello, Emanuela Di Giacomo, Mariam Grazia Polito, Margherita Rimini and Andrea Casadei-Gardini

You can read the Full Article on Springer Nature

Mario Balsa: Real-world Comparison in Advanced HCC - Atezolizumab + Bevacizumab vs Tremelimumab + Durvalumab

More posts featuring Mario Balsa.

atezolizumab Bevacizumab cancer Durvalumab Emanuela Di Giacomo Federica Lo Prinzi Federico Rossari Francesco Vitiello HCC hepatocellular carcinoma Mara Persano Margherita Rimini Mariam Grazia Polito Marianna Silletta Mario Balsa OncoDaily Oncology Silvia Camera Silvia Foti Tremelimumab
Special Coverage
Science
Jun 25, 2025, 09:27
Mario Balsa: Real-world Comparison in Advanced HCC - Atezolizumab + Bevacizumab vs Tremelimumab + Durvalumab
Blog
Jun 25, 2025, 09:08
Laura Bukavina: How Do We Predict Patients with True CR Using Urine Biomarkers?
Science
Jun 25, 2025, 09:08
Myeloma Paper of the Day, June 25th, suggested by Robert Orlowski
Blog
Jun 25, 2025, 09:07
Mikkael Sekeres: Can BPAs, PFAS, or Phthalates in Everyday Household Items Can Cause Cancer?
Insight
Jun 25, 2025, 09:00
Stephen V Liu on Phase 2 Study of Irinotecan plus Anlotinib for Platinum-Resistant SCLC
Insight
Jun 25, 2025, 08:59
David Tougeron Shared Study on Prognostic Tool for Third-Line Chemotherapy in Unresectable Pancreatic Cancer
Insight
Jun 25, 2025, 08:58
Zainul Aabideen Shared Details Upcoming "Pediatric Bone Marrow Transplant Course 2025"
Blog
Jun 25, 2025, 08:57
Digestive Cancers Europe Prepares for 10th DiCE Masterclass in Barcelona
Blog
Jun 25, 2025, 08:48
50 States in 50 Days with Ryan Trahan and Kia for Raising Awareness and Funds for Kids - St. Jude Children's Research Hospital
Blog
Jun 25, 2025, 08:46
Wee Joo Chng: We Concluded Another International Myeloma Study Group Summit - The Progress Has Been Tremendous
Dialogues
Jun 25, 2025, 08:45
Women Leaders in Oncology: Tara Frenkl on Hope, Elinzanetant, and HER2+ Lung Cancer Advances
Blog
Jun 25, 2025, 08:44
Luigi Formisano: Hot Topics at the 2025 GUiding INNOVATION Meeting